Logo

Neurome to Acquire TOGA Gene-Expression Platform, All Other Assets from Digital Gene Technologies

Aug 11, 2004

NEW YORK, Aug. 11 (GenomeWeb News) - Neurome plans to buy "substantially all" the assets owned by Digital Gene Technologies, including its gene-expression assays and gene-expression-analysis platform called TOGA, the companies said yesterday.

 

Neurome, which develops databases that depict and integrate gene-expression patterns of the brain, will also acquire DGT's entire patent estate. This includes data and discoveries generated in commercial and academic research programs.

Terms of the acquisition were not disclosed.

 

Neurome and DGT are both based in La Jolla, Calif.

Breaking News
The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.